Originally posted by jamesbrown
View Post
- Visitors can check out the Forum FAQ by clicking this link. You have to register before you can post: click the REGISTER link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. View our Forum Privacy Policy.
- Want to receive the latest contracting news and advice straight to your inbox? Sign up to the ContractorUK newsletter here. Every sign up will also be entered into a draw to WIN £100 Amazon vouchers!
Reply to: Actual good news
Collapse
You are not logged in or you do not have permission to access this page. This could be due to one of several reasons:
- You are not logged in. If you are already registered, fill in the form below to log in, or follow the "Sign Up" link to register a new account.
- You may not have sufficient privileges to access this page. Are you trying to edit someone else's post, access administrative features or some other privileged system?
- If you are trying to post, the administrator may have disabled your account, or it may be awaiting activation.
Logging in...
Previously on "Actual good news"
Collapse
-
5. Settle with FTC for tens of millions (and give hundre millions to current party in power)
-
Well, yeah, except for the being illegal part.Originally posted by DimPrawn View PostHow to become rich quickly.
1. Buy stock in your own company
2. Announce that your wonder drug cures covid without any peer review or clinical trial
3. Sell stock
4. Retire a billionaire.
Leave a comment:
-
How to become rich quickly.
1. Buy stock in your own company
2. Announce that your wonder drug cures covid without any peer review or clinical trial
3. Sell stock
4. Retire a billionaire.
Leave a comment:
-
However:
An academic has expressed concern that the Synairgen trial of the interferon beta drug SNG001, that seems to have had remarkably successful results, was not registered in advance (ie, notified formally to other researchers). Steve Goodacre, professor of emergency medicine at the University of Sheffield, said that he needed to know more from the company about how the trial was carried out before he could evaluate its significance. In a statement he said:
These results are not interpretable. We need the full details and, perhaps more importantly, the trial protocol. The trial should have been registered and a protocol made available before any analysis was undertaken. They could easily have included a link to the trial protocol in their press release. I am concerned they have not done this.
The trial protocol will provide crucial details, such as what the primary outcome measure was and whether the trial was designed to detect the differences in outcome reported in their press release. As it stands, we have no way of knowing whether the trial was designed to detect the positive outcomes reported in the press release (which would be more convincing) or whether these are just serendipitous findings from a trial that was designed for another purpose (which would be bad reporting practice).
I would therefore ask them to provide the trial registration details and trial protocol before commenting further.
Leave a comment:
-
Actual good news
"The preliminary results of a clinical trial suggest a new treatment for Covid-19 dramatically reduces the number of patients needing intensive care, according to the UK company that developed it.
The treatment from Southampton-based biotech Synairgen uses a protein called interferon beta which the body produces when it gets a viral infection.
The protein is inhaled directly into the lungs of patients with coronavirus, using a nebuliser, in the hope that it will stimulate an immune response.
The initial findings suggest the treatment cut the odds of a Covid-19 patient in hospital developing severe disease - such as requiring ventilation - by 79%."
Coronavirus: Protein treatment trial 'a breakthrough' - BBC News
That's really good if true, especially given that it sounds like it can be administered via nebuliser - now we need aggressive testing/tracing and early infected hopefully will get this to reduce chances of getting seriously ill, would be great if it holds up!Tags: None
- Home
- News & Features
- First Timers
- IR35 / S660 / BN66
- Employee Benefit Trusts
- Agency Workers Regulations
- MSC Legislation
- Limited Companies
- Dividends
- Umbrella Company
- VAT / Flat Rate VAT
- Job News & Guides
- Money News & Guides
- Guide to Contracts
- Successful Contracting
- Contracting Overseas
- Contractor Calculators
- MVL
- Contractor Expenses
Advertisers

Leave a comment: